Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Samsung’s Galaxy Watch 6 to Introduce FDA-Approved Heart-Rate Monitoring Feature

Samsung Galaxy Watch Tips Tricks And Features

Samsung announced today that the IHRN (Irregular Heart Rhythm Notification) component of the existing ECG (Electrocardiogram) feature on Galaxy Watches received FDA clearance. Galaxy Watch users will soon be able to use the BioActive Sensor on their Wear OS wearables to look for signs of atrial fibrillation (AFib).

Samsung says the FDA-cleared IHRN feature will debut on the upcoming Galaxy Watch 6 smartwatch series as part of One UI 5 Watch. The series is rumored to consist of a standard model and a Classic variant that should have a physical rotating bezel.

The company also says that the FDA-approved IHRN feature will expand to previous Galaxy Watch editions after the Watch 6 series debuts.

According to the company, the FDA-cleared IHRN feature is activated within the Samsung Health Monitor app and runs in the background using the BioActive Sensor to detect irregular heart rhythms. This feature was initially introduced with the Galaxy Watch 4 series, meaning it will be available on Watch 4 and subsequent models.

The availability of this feature is also confirmed by the upcoming One UI 5 Watch update, which will be exclusive to Wear OS Galaxy smartwatches and will not be available on older Tizen-powered models like the Galaxy Watch 3.

Samsung is expected to unveil the Galaxy Watch 6 series at an early Unpacked event, potentially taking place in late July. The release of the One UI 5 Watch update is scheduled to follow. Recently, Samsung officially announced some of the features of the upcoming smartwatch update, including improved sleep tracking, personalized heart rate zones, and enhanced safety features like Fall Detection and automatic SOS calls.

 

The tech giant emphasizes that this latest development serves as another illustration of Samsung’s commitment to proactive safety solutions, as well as their dedication to empowering users with a comprehensive understanding of their cardiovascular and overall health.

Source: sammobile

Leave a Reply

Your email address will not be published. Required fields are marked *